Endocrine-metabolic effects of asthma treatment the impact of glucocorticoid therapy in the elderly

Immunology and Allergy Clinics of North America

Volumn 17, Issue 4, 1997, Pages 701-726

  Ahmann, Andrew J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0007490192     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(05)70338-6     Document Type: Article

References (180)

1. Adachi JD, Cranney A, Goldsmith CH, et al: Intermittent cyclic therapy with etidronate in the prevention of corticosteroid-induced bone loss. J Rheumatol 21:1922, 1994
2. Adachi JD, Bensen WG, Bianchi F, et al: Vitamin D and calcium in the prevention of corticosteroid-induced osteoporosis: A 3-year follow-up. J Rheumatol 23:995, 1996
3. Adams JS, Wahl TO, Luckert BP: Effects of hydrochlorthiazide and dietary sodium restriction on calcium metabolism in corticosteroid-treated patients. Metabolism 30:217, 1981
4. Adelman R: Secretion of insulin during aging. J Am Geriatr Soc 37:983, 1989
5. Adinoff AD, Hollister JR: Steroid-induced fractures and bone loss in asthma. N Engl J Med 309:265, 1983
6. Adler RA, Rosen CJ, Robinson AM, et al: Glucocorticoids and osteoporosis. Endocrinol Metab Clin North Am 23:641, 1994
7. Agertoft L, Pedersen S: A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbohaler and fluticasone propionate Diskhaler. J Allergy Clin Immunol 99:773, 1997
8. Ali NJ, Capewell S, Ward MJ: Bone turnover during high dose inhaled corticosteroid treatment. Thorax 46:160, 1991
9. Allen SC, Prior A: What determines whether an elderly patient can use a metered dose inhaler correctly? British Journal of Disease of the Chest 80:45, 1986
10. Aloia JF, Flaster ER: Estimating the risk of fracture in osteopenic patients. The Endocrinologist 5:397, 1995
11. Als OS, Gotfredsen A, Christiansen C: The effect of glucocorticoids on bone mass in rheumatoid arthritis patients: Influence of menopausal state. Arthritis Rheum 28:369, 1995
12. Altman LC, Findlay SR, Lopez M, et al: Adrenal function in adult asthmatics during long-term daily treatment with 800, 1200, and 1600 mcg triamcinolone acetonide. Chest 101:1250, 1992
13. American College of Rheumatology Task Force on Osteoporosis Guidelines: Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 39:1791, 1996
14. Anonymous: Asthma in adults and school children. Thorax 52(suppl 1):S2, 1997
15. Ariyananda PL, Agnew JE, Clarke SW: Aerosol delivery systems for bronchial asthma. Postgrad Med J 72:151, 1996
16. Arner P, Gunnersson R, Blomdahl S, et al: Some characteristics of steroid diabetes: A study in renal-transplant patients receiving high-dose corticosteroid therapy. Diabetes Care 6:23, 1983
17. Axelrod L: Corticosteroid therapy. In Becker KL (ed): Principles and Practice of Endocrinology and Metabolism, ed 2. Philadelphia, JB Lippincott, 1996, p 695
18. Banerjee DK, Lee GS, Malik SK, et al: Underdiagnosis of asthma in the elderly. British Journal of Disease of the Chest 81:23, 1987
19. Barnes PJ: Inhaled glucocorticoids for asthma. N Engl J Med 332:868, 1995
20. Barnes PJ: Molecular mechanisms of steroid action in asthma. J Allergy Clin Immunol 97:159, 1996
21. Bauer BA, Reed CE, Yunginger JW, et al: Incidence and outcomes of asthma in the elderly. Chest 111:303, 1997
22. Birkeback NH, Esberg G, Andersen K, et al: Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate. Arch Dis Child 73:524, 1995
23. Boorsma M, Anderson N, Carason P, et al: Assessment of the relative potency of inhaled fluticasone and budesonide. Eur Respir J 9:1427, 1996
24. Bootsma GP, Dekhuijzen PNR, Festen J, et al: Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate. Am J Respir Crit Care Med 153:924, 1996
25. Boyle PJ: Cushings' disease, glucocorticoid excess, glucocorticoid deficiency, and diabetes. Diabetes Reviews 1:301, 1993
26. Braithwaite SS, Barr WG, Thomas JD: Diabetes management during glucocorticoid therapy for nonendocrine disease. Endocrine Practice 2:320, 1996
27. Braltsand R, Thalen A, Roempke K, et al: Development of new glucocorticoids with a very high ratio between topical and systemic activities. Eur J Resp Dis 63(suppl 122):62, 1982
28. Braude AC, Rebuck AS: Pulmonary disposition of cortisol. Ann Intern Med 97:59, 1982
29. Brigell DF, Fang VS, Rosenfield RL: Recovery of responses to ovine corticotropin-releasing hormone after withdrawal of a short course of glucocorticoid. J Clin Endocrinol Metab 74:1036, 1992
30. Broide J, Soferman R, Kivity S, et al: Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids. J Clin Endocrinol Metab 80:1243, 1995
31. Bromberg JS, Alfrey EJ, Barker CF, et al: Adrenal suppression and steroid supplementation in renal transplant recipients. Transplantation 51:385, 1991
32. Brown PH, Blundell G, Greening AP, et al: Do large volume spacer devices reduce the systemic effects of high-dose inhaled corticosteroids? Thorax 45:736, 1990
33. Brown PH, Blundell G, Greening AP, et al: High-dose inhaled corticosteroids and the cortisol stress response to acute severe asthma. Respir Med 86:495, 1992
34. Brown PH, Matusiewicz SP, Shearing C, et al: Systemic effect of high dose inhaled steroids: Comparison of beclomethasone dipropionate and budesonide in healthy subjects. Thorax 48:967, 1993
35. Buckley LM, Leib ES, Cartularo KS, et al: Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med 125:967, 1996
36. Burrow B, Barbee RA, Cline MG, et al: Characteristics of asthma among elderly adults in a sample of the general population. Chest 100:935, 1991
37. Canalosi E: Mechanisms of glucocorticoid action in bone: Implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81:3441, 1996
38. Carryer HM, Koelsche GA, Prickman LE, et al: The effect of cortisone in bronchial asthma and hay fever occurring in subjects sensitive to ragweed pollens. Journal of Allergy 21:282, 1950
39. Check WA, Kaliner MA: Pharmacology and pharmacokinetics of topical corticosteroid derivatives used for asthma. American Review of Respiratory Disease 141:S44, 1990
40. Chervinsky P: Treatment of steroid-dependent asthma with triamcinolone acetonide aerosol. Annals of Allergy 38:192, 1977
41. Clark DJ, Grove A, Cargill RI, et al: Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Thorax 51:262, 1996
42. Crilly RG, Cawood M, Marshal DH, et al: Hormonal status in normal, osteoporotic and corticosteroid treated postmenopausal women. J R Soc Med 71:733, 1978
43. Curtiss PH, Clark WS, Herndon CH: Vertebral fractures resulting from prolonged cortisone and corticotrophin therapy. JAMA 156:467, 1954
44. Cushing H: The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bulletin of Johns Hopkins Hospital 1:137, 1932
45. Dahl R, Lundback B, Mulo J, et al: A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. Chest 104:1352, 1993
46. Dempster D: Perspective: Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res 4:137, 1989
47. Diamond T, McGuigan L, Barbagallo S, et al: Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women. Am J Med 98:459, 1995
48. Dickstein G, Chechnere C, Nicholson WE, et al: Adrenocorticotropin stimulation test: Effects of basal cortisol level, time of day and suggested new sensitive low-dose test. J Clin Endocrinol Metab 72:773, 1991
49. Djykanovic R, Homeyard S, Cratziva C, et al: The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation. Am J Resp Crit Care Med 155:826, 1997
50. Dow L, Holgate ST: Assessment and treatment of obstructive airways disease in the elderly. British Medical Bulletin 46:230, 1990
51. Dykman TR, Haralson KM, Cluch OS, et al: Effect of 1,25 dihydroxyvitamin D and calcium in glucocorticoid-induced osteopenia in patients with rheumatic disease. Arthritis Rheum 27:1336, 1984
52. Dykman T, Gluck O, Murphy W, et al: Evaluation of factors associated with glucocorticoid induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 23:361, 1985
53. Ebden P, McNally P, Samanta A, et al: The effects of high-dose inhaled beclomethasone dipropionate on glucose and lipid profiles in normal and diet-controlled diabetic patients. Respir Med 83:289, 1989
54. Fanta CH, Rossing TH, McFadden ER Jr: Glucocorticoids in acute asthma: A critical controlled trial. Am J Med 74:845, 1983
55. Farrer M, Francis AJ, Pearce SJ: Morning serum cortisol concentrations after 2 mg inhaled beclomethasone dipropionate in normal subjects: Effect of a 750 mg spacing device. Thorax 45:740, 1990
56. Fiad TM, Kirby JM, Cunningham SK, et al: The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis. Clinical Endocrinology 40:603, 1994
57. Fish HR, Chernow B, O'Brian JT: Endocrine and neurophysiologic response of the pituitary to insulin-induced hypoglycemia: A review. Metabolism 8:763, 1986
58. Fleisch HA: Bisphosphonate: Preclinical aspects and use in osteoporosis. Ann Med 29:55, 1997
59. Gallacher SJ, Fenner JAK, Anderson K, et al: Intravenous pamidronate in the treatment of osteoporosis associated with corticosteroid-dependent lung disease: An open pilot study. Thorax 47:932, 1992
60. Gambert SR, Schultz BM, Hamdy RC: Osteoporosis: Clinical features, prevention and treatment. Endocrinol Clin North Am 24:317, 1995
61. Giori PL, Oggiana N, Biraghi M, et al: Effect of high doses of inhaled flunisolide on hypothalamic-pituitary-adrenal axis function in children with asthma. Current Therapy Research 49:778, 1991
62. Gluck OS, Murphy WA, Hahn RJ, et al: Bone loss in adults receiving alternate day glucocorticoid therapy: A comparison with daily therapy. Arthritis Rheum 24:892, 1981
63. Goldberg S, Algur N, Levi M, et al: Adrenal suppression among asthmatic children receiving chronic therapy with inhaled corticosteroid with and without spacer device. Ann Allergy Asthma Immunol 76:234, 1996
64. Goldstein DE, Konig P: Effect of inhaled beclomethasone dipropionate on hypothalamic-pituitary-adrenal axis function in children with asthma. Pediatrics 72:60, 1983
65. Gradman TJ, Laws A, Thompson LW, et al: Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. J Am Geriatr Soc 41:1305, 1993
66. Greenstone MA, Shaw AB: Alternate day corticosteroid causes alternate day hyperglycemia. Postgrad Med J 63:761, 1987
67. Gurwitz JH, Bohn RI, Glynn RJ: Glucocorticoids and the risk for initiation of hypoglycemic therapy. Arch Intern Med 154:97, 1994
68. Gustafsson P, Tsanakas J, Gold M, et al: Comparison of the efficacy and safety of inhaled fluticasone propionate 200 mcg/day with inhaled beclomethasone dipropionate 400 mcg/day in mild and moderate asthma. Arch Dis Child 69:206, 1993
69. Haahtela T, Jarvinen M, Kava T, et al: Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 331:700, 1994
70. Hall GM, Daniels M, Doyle DV, et al: Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids. Arthritis Rheum 37:1499, 1994
71. Hanania NA, Chapman KR, Sturtridge WC, et al: Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 96:571, 1995
72. Harris MI: Summary. In Harris MI, Cowie CC, Stern MD, et al (eds): Diabetes In America, 2nd ed, National Institutes of Health. NIH Publication 95-1468, 1995, p 1
73. Hatoum HT, Schumock GT, Kendzierski DL: Metaanalysis of controlled trials of drug therapy in mild chronic asthma: The role of inhaled corticosteroids. Ann Pharmacother 28:1285, 1994
74. Healy JA, Paget SA, Williams-Russo P, et al: A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica. Calcif Tissue Int 58:73, 1996
75. Hodsman AB, Toogood JH, Jennings B, et al: Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin. J Clin Endocrinol Metab 72:530, 1991
76. Hoekx JCM, Hedlin G, Pedersen W, et al: Fluticasone propionate compared with budesonide: A double-blind trial in asthmatic children using powder devices at a dosage of 400 mcg/day. Eur Respir J 9:2263, 1996
77. Holgate ST, Dow L: Airway disease in the elderly: An easy to miss diagnosis. Journal of Respiratory Disease 9:14, 1988
78. Ip M, Lam K, Yam L, et al: Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroids. Chest 105:1722, 1994
79. Jackevicius CA, Chapman KR: Prevalence of inhaled corticosteroids use among patients with chronic obstructive pulmonary disease: A survey. Ann Pharmacother 31:160, 1997
80. Jennings BH, Andersson K-E, Johansson SA: Assessment of systemic effects of inhaled glucocorticoids: Comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover. Br J Clin Pharmacol 40:77, 1991
81. Johnson M: Pharmacodynamics and pharmacokinetics of inhaled corticosteroids. J Allergy Clin Immunol 97:169, 1996
82. Kamada AK, Szefler SJ, Martin RJ, et al: Issues in the use of inhaled glucocorticoids. Am J Respir Crit Care Med 153:1739, 1996
83. Kamada AK, Szefler SJ: How should inhaled glucocorticoids be compared? J Allergy Clin Immunol 99:735, 1997
84. Kaplan FS, Scherl JD, Wisnesk R, et al: The cluster phenomenon in patients who have multiple vertebral compression fractures. Clin Orthop 297:161, 1993
85. Katsunuma T, Akasawa A, Iikura Y: Adrenal function of children with bronchial asthma treated with beclomemasone dipropionate. Annals of Allergy 69:529, 1992
86. Kershnar H, Klein R, Waldman D, et al: Treatment of chronic childhood asthma with beclomethasone dipropionate aerosol: II Effect on pituitary-adrenal function after substitution for oral corticosteroids. Pediatrics 62:189, 1978
87. Kim CS, Eldridge MA, Sackner MA: Oropharyngeal deposition and delivery aspects of meter-dose inhaler aerosols. American Review of Respiratory Disease 135:157, 1987
88. King H, Rewers M: World Health Organization Ad Hoc Diabetes Reporting Group: Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care 16:157, 1993
89. Kiviranta K, Turpeinen M: Effect of eight months of inhaled beclomethasone propionate and budesonide on carbohydrate metabolism in adults with asthma. Thorax 48:974, 1993
90. Kraus-Friedman N: Hormonal regulation of hepatic gluconeogenesis. Physiological Reviews 64:179, 1984
91. Kruszynska YT, Greenstone M, Home PD, et al: Effect of high-dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects. Thorax 42:881, 1987
92. Laan R, Burjs W, van Erning L, et al: Differential effects of glucocorticoids on cortical, appendicular and cortical vertebral bone mineral content. Calcif Tissue Int 52:5, 1993
93. Laan RFJM, van Riel PLCM, van de Putti LBA, et al: Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. Ann Intern Med 119:963, 1993
94. Laursen LC, Taudorf E, Weeke B: High-dose inhaled budesonide in treatment of severe steroid-dependent asthma. Eur J Respir Dis 68:19, 1986
95. Leblanc P, Mink S, Kerstinen T, et al: A comparison of fluticasone propionate 200 mcg/day with beclomethasone dipropionate 400 mcg/day in adult asthma. Allergy 49:380, 1994
96. Liberman UA, Weiss Sr, Broll J, et al: Effect of oral alendronate in bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333:1437, 1995
97. LoCascio V, Bonnucci E, Imbimbo B, et al: Bone loss in response to long-term glucocorticoid therapy. Bone and Mineral 8:39, 1990
98. Lonnebo A, Grahnen A, Jansson B, et al: An assessment of the systemic effects of single and repeated doses of inhaled fluticasone and inhaled budesonide in healthy volunteers. Eur J Clin Pharmacol 49:459, 1996
99. Luckert BP, Raisz LG: Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann Intern Med 112:352, 1990
100. Luckert BP, Raisz LG: Glucocorticoid-induced osteoporosis. Rheum Dis Clin North Am 20:629, 1994
101. Luckert BP, Raisz LG: Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann Intern Med 112:352, 1990
102. Luckert BP, Johnson BE, Robinson RG: Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone Miner Res 7:1063, 1992
103. Luengo M, Picado C, Piera C, et al: Intestinal calcium absorption and parathyroid hormone secretion in asthmatic patients on prolonged oral or inhaled steroid treatment. Eur Respir J 4:441, 1991
104. Luengo M, Pons F, Martinez de Osabo MJ, et al: Prevention of further bone loss by nasal calcitonin in patients on long-term glucocorticoid therapy for asthma: A two year follow up study. Thorax 49:1099, 1994
105. Lufkin EG, Warmer HW, Gergstralh EJ: Reversitility of steroid-induced osteoporosis. Am J Med 85:887, 1988
106. MacAdams MR, White RH, Chipps BE: Reduction in serum testosterone levels during chronic glucocorticoid therapy. Ann Intern Med 648:651, 1986
107. Marco J, Calle C, Roman D, et al: Hyperglycagonism induced by glucocorticoid treatment in man. N Engl J Med 288:128, 1973
108. McCubbin MM, Milavetz G, Grandgeorge S, et al: A bioassay for topical and systemic effect of three inhaled corticosteroids. Clin Pharmacol Ther 57:455, 1995
109. McMahon M, Gerich J, Rizza R: Effect of glucocorticoids on carbohydrate metabolism. Diabetes Metab Rev 4:17, 1988
110. Meeran K, Hattersley A, Burrin J, et al: Oral and inhaled corticosteroids reduce bone formation as shown by the plasma osteocalcin levels. Am J Respir Crit Care Med 151:333, 1995
111. Mulder H, Struys A: Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss. Br J Rheumatol 33:348, 1994
112. National Heart, Lung and Blood Institute: NAEPP Working Group Report: Considerations for diagnosing and managing asthma in the elderly. National Institutes of Health Pub No. 96-3662. Bethesda, MD, 1996
113. National Heart, Lung, and Blood Institute: National Asthma Educational Prevention Program Expert Panel Report. Guidelines for the Diagnosis and Management of Asthma. National Institutes of Health Publications, Bethesda, MD 1997
114. Neville RG, Hoskins G, Smith B, et al: How general practitioners manage acute asthma attacks. Thorax 52:153, 1997
115. Noonan M, Chervinsky P, Busse WW, et al: Fluticasone propionate reduces oral prednisone use while it improves asthma control. American Journal of Therapeutics 3:1, 1996
116. Nosadini R, Del Prato S, Tiengo A, et al: Insulin resistance in Cushings' syndrome. J Clin Endocrinol Metab 57:529, 1983
117. Novey HS, Beall G: Aerosolized steroids and induced Cushing's syndrome. Arch Intern Med 115:602, 1965
118. O'Bryne P, Cuddy L, Taylor DW, et al: Efficacy and cost benefit of inhaled corticosteroids in patients considered to have mild asthma in primary care practice. Canadian Respiratory Journal 3:169, 1996
119. Packe GE, Douglas JG, McDonald AF, et al: Bone density in asthmatic patients taking high-dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. Thorax 47:414, 1992
120. Packe GE, Robb O, Robins SP, et al: Bone density in asthmatic patients taking inhaled corticosteroids: Comparison of budesonide and beclomethasone. Journal of the Royal College of Physicians of London 30:128, 1996
121. Pagano G, Cavollo-Perin P, Cassader M, et al: An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest 72:1814, 1983
122. Peacey SR, Guo C-Y, Robinson AM, et al: Glucocorticoid replacement therapy: Are patients over treated and does it matter? Clinical Endocrinology 46:255, 1997
123. Peck WA: Consensus development conference: Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94:646, 1993
124. Pedersen S, Hansen OR: Budesonide treatment of moderate and severe asthma in children: A dose-response study. J Allergy Clin Immunol 95:29, 1995
125. Pensaben-Jasper T, Panush RS: Corticosteroid usage: Observations at a community hospital. Am J Med Sciences 311:234, 1996
126. Perley N, Kipnis DM: Effect of glucocorticoids on plasma insulin. N Engl J Med 274:1237, 1966
127. Pincus DJ, Szefler SJ, Ackerson LM, et al: Chronotherapy of asthma with inhaled steroids: The effect of dosage timing on drug efficacy. J Allergy Clin Immunol 95:1172, 1995
128. Pouw EM, Prummel MF, Oostig H, et al: Beclomethasone inhalation decreases serum osteocalcin level. Br Med J 302:302-627, 1991
129. Prahl P, Jensen T, Bjerregaurd-Anderson: Adrenocortical function in children on high-dose steroid aerosol therapy. Allergy 42:541, 1987
130. Prahl P: Adrenocortical suppression following treatment with beclomethasone and budesonide. Clin Exp Allergy 21:145, 1991
131. Pupo AA, Wajchengerg BL, Schnaider J: Carbohydrate metabolism in hyperadrenocorticism. Diabetes 15:24, 1966
132. Reid IR, France JT, Pybus J, et al: Low plasma testosterone levels in glucocorticoid-treated male asthmatics. Br Med J 291:574, 1985
133. Reid IR, Ibberteon HK: Calcium supplements in the prevention of steroid-induced osteoporosis. Am J Clin Nutr 44:287, 1986
134. Reid IR, Heap SW: Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy. Arch Intern Med 150:2545, 1990
135. Reid IR, Wattie OJ, Evans MC, et al: Testosterone therapy in glucocorticoid-treated men. Arch Intern Med 156:1173, 1996
136. Rizza RA, Mandarino LJ, Gerich JE: Cortisol-induced insulin resistance in man: Impaired suppression of glucose production and stimulation of glucose utilization due to a post receptor defect of insulin action. J Clin Endocrinol Metab 54:131, 1982
137. Rowe BH, Keller JL, Oxman AD: Effectiveness of steroid therapy in acute exacerbations of asthma: A meta-analysis. Am J Emerg Med 10:301, 1992
138. Ruegsegger P, Medici TC, Anliker M: Corticosteroid-induced bone loss: A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 25:615, 1983
139. Sakakura M, Takebe K, Nakagawa S: Inhibition of luteinizing hormone secretion induced by synthetic LRH by long-term treatment with glucocorticoids in human subjects. J Clin Endocrinol Metab 40:774, 1975
140. Salem M, Tainsh RE Jr, Brombery J, et al: Perioperative glucocorticoid coverage: A reassessment 42 years after emergence of a problem. Ann Surg 219:416, 1994
141. Salmeron S, Guerin J-C, Godard R, et al: High doses of inhaled corticosteroids in unstable chronic asthma. American Review of Respiratory Disease 140:167, 1989
142. Sambrook P, Birmingham J, Kelly P, et al: Prevention of corticosteroid osteoporosis: A comparison of calcium, calcitriol and calcitonin. N Engl J Med 328:1747, 1993
143. Schatz M, Dudl J, Zeiger RS, et al: Osteoporosis in corticosteroid-treated asthmatic patients: Clinical correlates. Allergy Proceedings 14:341, 1993
144. Schwiebert LA, Beck LA, Stellato C, et al: Glucocorticosteroid inhibition of cytokine production: Relevance to anti-allergic actions. J Allergy Clin Immunol 97:143, 1996
145. Seeman E, Wagner HW, Offord KP, et al: Differential effects of endocrine dysfunction on the axial and appendicular skelton. J Clin Invest 69:1302, 1982
146. Seeman TE, Robbins RJ: Aging and hypothalamic-pituitary-adrenal response to challenge in humans. Endocr Rev 15:233, 1994
147. Selroos O, Pientinalho A, Lofroos A, et al: Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 108:1228, 1995
148. Siegel SC, Heimlich EM, Richards W, et al: Adrenal function in allergy, IV: Effect of dexamethasone aerosols in asthmatic children. Pediatrics 33:245, 1964
149. Simmons R, Miles J, Gerich J, et al: Increased proteolysis: An effect of increases in plasma cortisol within the physiologic range. J Clin Invest 73:412, 1984
150. Singh I, Marshall MC Jr: Diabetes in the elderly. Endocrinol Metab Clin North Am 24:255, 1995
151. Smith MJ, Hodson ME: Effects of long-term inhaled high dose beclomethasone dipropionate on adrenal function. Thorax 38:676, 1983
152. Smyrnios NA: Asthma: A six-part strategy for managing older patients. Geriatrics 52:36, 1997
153. Sowers MF: Clinical epidemiology and osteoporosis: Measures and their interpretation. Endocrinol Metab Clin North Am 26:219, 1997
154. Streck WF, Lockwood DH: Pituitary adrenal recovery following short-term suppression with corticosteroids. Am J Med 66:910, 1979
155. Struys A, Snelder AA, Mulder H: Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis. Am J Med 99:235, 1995
156. Svendsen UG, Frolund L, Heinig JH, et al: High-dose inhaled steroids in the management of asthma. Allergy 47:174, 1992
157. Szefler SJ: Glucocorticoid therapy for asthma: Clinical pharmacology. J Allergy Clin Immunol 88:147, 1991
158. Takahashi PY, Levine J, Mantilla C, et al: Inhaled corticosteroids and bone density. Chest 107:1477, 1995
159. The Expert Committee On the Diagnosis and Classification of Diabetes Mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183, 1997
160. Toogood JH, Lefwe NM, Haines DSM, et al: A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma. J Allergy Clin Immunol 59:298, 1977
161. Toogood JH, Baskerville J, Jennings B, et al: Use of spacers to facilitate inhaled corticosteroid treatment of asthma. American Review of Respiratory Disease 129:723, 1984
162. Toogood JH, Crilly RG, Jones G, et al: Effect of high-dose inhaled budesonide on calcium and phosphate metabolism and the risk of osteoporosis. American Review of Respiratory Disease 138:57, 1988
163. Toogood JH, Baskerville J, Jenning B, et al: Bioequivalent doses of budesonide and prednisone in moderate and severe asthma. J Allergy Clin Immunol 84:688, 1989
164. Toogood JH: High-dose inhaled steroid therapy for asthma. J Allergy Clin Immunol 83:528, 1989
165. Toogood JH, Jennings B, Hodsman AB, et al: Effects of dose and dosing schedule of inhaled budesonide on bone turnover. J Allergy Clin Immunol 88:572, 1991
166. Toogood JH, Baskerville JC, Markov AE, et al: Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy. J Allergy Clin Immunol 96:157, 1995
167. Toogood JH, White FA, Baskerville JC, et al: Comparison of the antiasthmatic, oropharyngeal and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbohaler dry powder inhaler. J Allergy Clin Immunol 99:186, 1997
168. Turpeinen M, Sorva R, Juntunen-Backman K: Changes in carbohydrate and lipid metabolism in children with asthma inhaling budesonide. J Allergy Clin Immunol 88:384, 1991
169. Urena P, lida-Klein A, Kong X-F, et al: Regulation of parathyroid hormone (PTH)/ PTH-related peptide receptor messenger ribonucleic acid by glucocorticoids and PTH in ROS 17/28 and OK cells. Endocrinology 134:451, 1994
170. Vachier I, Roux S, Chanez P, et al: Glucocorticoid induced down-regulation of glucocorticoid receptor mRNA expression in asthma. Clin Exp Immunol 103:311, 1996
171. Verbeek PR, Geerts WH: Nontapering versus tapering prednisone in acute exacerbations of asthma: A pilot trial. J Emerg Med 13:715, 1995
172. Villareal MS, Klaustermeyer WB, Hahn TF, et al: Osteoporosis in steroid dependent asthma. Ann Allergy Asthma Immunol 76:369, 1996
173. Volovitz B, Kayschansky A, Nussinovitch M, et al: Normal diurnal variation in serum cortisol concentration in asthmatic children treated with inhaled budesonide. J Allergy Clin Immunol 96:874, 1995
174. Walsh LJ, Wong CA, Pringle M, et al: Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: A cross sectional study. Br Med J 313:344, 1996
175. Weinstein SP, Holand A, O'Boyle E, et al: Effects of thiazolidinediones on glucocorticoid-induced insulin resistance and GLUT4 glucose transporter expression in rat skeletal muscle. Metabolism 42:1365, 1993
176. Weis KB, Gergen PJ, Hodgson TA: An economic evaluation of asthma in the United States. N Engl J Med 326:862, 1992
177. Weiss KB, Wagener DK: Asthma surveillance in the United States - a review of current trends and knowledge gaps. Chest 98:179S, 1990
178. Wolfe JD, Selner JC, Mendelson LM, et al: Effectiveness of fluticasone propionate in patients with moderate asthma: A dose-ranging study. Clin Ther 18:635, 1996
179. Worth H, Stammen D, Keck E: Therapy of steroid-induced bone loss in adult asthmatics with calcium, vitamin D, and a diphosphonate. Am J Respir Crit Care Med 150:394, 1994
180. ZuWallack RL, Rosen JP, Cohen L, et al: The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma control. J Allergy Clin Immunol 99:278, 1997